233 related articles for article (PubMed ID: 19346028)
21. Typhlitis during second-line chemotherapy with pemetrexed in non-small cell lung cancer (NSCLC): A case report.
Tiseo M; Gelsomino F; Bartolotti M; Barili MP; Ardizzoni A
Lung Cancer; 2009 Aug; 65(2):251-3. PubMed ID: 19346026
[TBL] [Abstract][Full Text] [Related]
22. Systemic therapy of advanced bronchioloalveolar cell carcinoma: challenges and opportunities.
Miller VA; Hirsch FR; Johnson DH
J Clin Oncol; 2005 May; 23(14):3288-93. PubMed ID: 15886316
[TBL] [Abstract][Full Text] [Related]
23. Pemetrexed and maintenance therapy for non-small cell lung cancer.
Prescrire Int; 2011 Feb; 20(113):39. PubMed ID: 21488588
[No Abstract] [Full Text] [Related]
24. Pemetrexed as a component of first-, second- and third- line chemotherapy in treating patients with metastatic lung adenocarcinoma.
Huang XE; Tian GY; Cao J; Xu X; Lu YY; Wu XY; Liu J; Shi L; Xiang J
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6663-7. PubMed ID: 24377585
[TBL] [Abstract][Full Text] [Related]
25. A semimechanistic-physiologic population pharmacokinetic/pharmacodynamic model for neutropenia following pemetrexed therapy.
Latz JE; Karlsson MO; Rusthoven JJ; Ghosh A; Johnson RD
Cancer Chemother Pharmacol; 2006 Apr; 57(4):412-26. PubMed ID: 16322990
[TBL] [Abstract][Full Text] [Related]
26. [Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar features: a clinico-pathological spectrum].
Cadranel J; Lavolé A; Gounant V; Wislez M
Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S165-70. PubMed ID: 18235410
[TBL] [Abstract][Full Text] [Related]
27. [Clinical types of thoracic cancer. Bronchiolo-alveolar carcinoma and adenocarcinoma with bronchioloalveolar features: a clinico-pathological spectrum].
Cadranel J; Lavolé A; Gounant V; Wislez M
Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S158-16S163. PubMed ID: 17268353
[TBL] [Abstract][Full Text] [Related]
28. New data integrating multitargeted antifolates into treatment of first-line and relapsed non-small-cell lung cancer.
Scagliotti GV; Selvaggi G
Clin Lung Cancer; 2008; 9 Suppl 3():S122-8. PubMed ID: 19419926
[TBL] [Abstract][Full Text] [Related]
29. A phase I/II study of neoadjuvant chemotherapy with Pemetrexed (Alimta) in rectal cancer.
Derwinger K; Kodeda K; Swartling T; Kälebo P; Carlsson G; Gustavsson B
Eur J Surg Oncol; 2011 Jul; 37(7):583-8. PubMed ID: 21550200
[TBL] [Abstract][Full Text] [Related]
30. [Second-line treatment of advanced non-small-cell lung cancer: role of pemetrexed].
Pérol M
Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S14-7. PubMed ID: 16273004
[No Abstract] [Full Text] [Related]
31. Successful treatment of refractory bronchioloalveolar carcinoma with S-1 (oral fluoropyrimidine).
Kobayashi S; Fujino N; Suzuki S; Yanai M
Respirology; 2009 Jul; 14(5):771-2. PubMed ID: 19659655
[TBL] [Abstract][Full Text] [Related]
32. Pemetrexed for the treatment of non-small-cell lung cancer.
Manegold C; Schmid-Bindert G; Pilz LR
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1195-209. PubMed ID: 19761423
[TBL] [Abstract][Full Text] [Related]
33. [Pemetrexed].
Sudoh J; Gemma A
Gan To Kagaku Ryoho; 2008 Jun; 35(6):1033-8. PubMed ID: 18633241
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of the characteristics in recurrence and metastasis between bronchioloalveolar carcinoma and other lung adenocarcinomas].
Zhong XJ; Li DT; Li XL; Mu DB; Zhang XG; Luo JY
Ai Zheng; 2007 Jul; 26(7):785-9. PubMed ID: 17626761
[TBL] [Abstract][Full Text] [Related]
35. The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases.
Garfield DH; Cadranel JL; Wislez M; Franklin WA; Hirsch FR
J Thorac Oncol; 2006 May; 1(4):344-59. PubMed ID: 17409882
[TBL] [Abstract][Full Text] [Related]
36. Pemetrexed: new indication. Untreated non-small cell lung cancer: just another cytotoxic drug. No better than the gemcitabine-cisplatin combination with a different safety profile, as is the case for other cytotoxic drugs.
Prescrire Int; 2009 Jun; 18(101):114. PubMed ID: 19637425
[No Abstract] [Full Text] [Related]
37. Phase II trial of premetrexed in patients with selected stage IIIB/IV bronchioloalveolar carcinoma.
Ho C; Ross H; Davies A
Clin Lung Cancer; 2006 Nov; 8(3):220-2. PubMed ID: 17239300
[No Abstract] [Full Text] [Related]
38. A case of pemetrexed-induced acute lung injury in non-small cell lung cancer.
Kim HO; Lee SY; Shim JJ; Kang KH; Shin BK
J Thorac Oncol; 2010 Mar; 5(3):401-2. PubMed ID: 20186027
[No Abstract] [Full Text] [Related]
39. Dramatic response to pemetrexed in a patient with pneumonic-type mucinous bronchioloalveolar carcinoma.
Garfield DH; Franklin W
J Thorac Oncol; 2011 Feb; 6(2):397-8. PubMed ID: 21252722
[No Abstract] [Full Text] [Related]
40. The potential role of pemetrexed in gastrointestinal cancer.
Meriggi F; Di Biasi B; Caliolo C; Zaniboni A
Chemotherapy; 2008; 54(1):1-8. PubMed ID: 18063861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
